BIO-key Q3 revenue up 33% to $1.8M, net loss per share narrows to ($0.08) from ($0.29)

BIO KEY INTERNATIONAL INC

Revenue $1.8M (+33% YoY); gross profit $1.4M (+43%); gross margin 77% vs 71%.
Operating loss improved to ~$750K from $2.4M; net loss per share ($0.08) vs ($0.29) in Q3'22.
Nine-month revenue $6.8M (+30%); net loss reduced to $2.5M from $5.1M in year-ago period.
ARR ~$7M; secured additional order from international defense ministry customer for expanded rollout.
Cash and equivalents $0.3M; seeking expense reductions including HQ relocation to reach breakeven.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BIO KEY INTERNATIONAL INC reported three and nine months ended September 30, 2023 results: revenue $1.8M, EPS ($0.08).

Period: three and nine months ended September 30, 2023
Revenue: $1.8M
EPS: ($0.08)
Result: preliminary results

Exact text from the filing

(EXHIBIT 99.1) --- EX-99.1 2 ex_585492.htm EXHIBIT 99.1 ex_585492.htm Exhibit 99.1 Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales Holmdel, NJ – October 25, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-23-028904

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.